Pharmacokinetics (PK) and Pharmacodynamics (PD) of Subcutaneous Versus Intravenous Administration of Bortezomib in Patients with Relapsed Multiple Myeloma: Effects of Subcutaneous Injection Site and Concentration, and Patient Characteristics
暂无分享,去创建一个
D. Esseltine | K. Venkatakrishnan | P. Moreau | X. Leleu | T. Facon | D. Skee | C. Hulin | A. Cakana | W. Deraedt | Huaibao Feng | V. Doronin | Ievgenii Karamanesht | Maryna Y. Kyselyova | S. Girgis | N. Domnikova | A. Schmidt | K. Vilchevska